<DOC>
	<DOCNO>NCT02921945</DOCNO>
	<brief_summary>In trial safety efficacy SCT800 ( B-domain delete recombinant factor VIII ) evaluate 50 subject , 12 65 year age , moderate severe Hemophilia A . These subject receive open label treatment SCT800 approximately 6 month on-demand treatment .</brief_summary>
	<brief_title>Efficacy Safety Study SCT800 On-demand Treatment With Patients With Hemophilia A</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>12 65 year old ; The activity coagulation factor VIII ( FVIII : C ) ≤5 % , previously treat FVIII concentrate ( ) minimum 50 exposure day ( EDs ) prior study entry Bleeding state need treat FVIII ; Negative assay FVIII inhibitor ( ＜0.6 BU/mL ) ; The platelet count normal； Normal prothrombin time INR ≤1.5； Given inform consent Hypersensitivity recombinant coagulation factor VIII concentrate excipients ; allergic heterologous protein ( e.g . murine , bovine hamster origin ) ; Family history history FVIII inhibitor ( ≥0.6 Bethesda Units [ BU ] mL1 ) ; Received infusion FVIII ondemand therapy prophylaxis within 4 day prior study entry ( include rFVIII , plasmaderived factor VIII [ pdFVIII ] , cryoprecipitate whole blood ) ; Significant hepatic renal impairment ( ALT AST ≥2×ULN ; BUN Cr≥2×ULN ) ; HIV seropositive ; Abnormal hemostasis cause hemophilia A； Patients severe heart disease , include myocardial infarction , heart failure ( III high level ) ; Patients receive anticoagulant antiplatelet therapy within one week ( include NSAIDs ) need receive anticoagulant antiplatelet therapy period clinical trial ; Alcoholism , drug abuse , mental disorder mental retardation ; Elective surgery plan process study ; Patients previously participate clinical trial prior study entry ; The patient parent/legal guardian unable unwilling sign inform consent form comply requirement clinical protocol ; Other condition confirm researcher , result patient unable benefit clinical observation ;</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>